Drug Research
Coriolis Pharma Expands ATMP Development Facilities
Coriolis Pharma, a provider of research and development of for (bio)pharmaceutical drugs, is expanding its advanced therapy medicinal products (ATMP) development facilities under biosafety level S2 (BSL2 / S2).
Re-construction of an existing building near the Coriolis headquarters started in...
Clinical Trials
Vectura, Incannex Enter Preclinical Services Agreement
Vectura Group plc, an inhalation CDMO, has signed an agreement with Incannex Healthcare Ltd., an Australian cannabinoid medicines development company, to provide preclinical development services for IHL-216A, Incannex’s proprietary inhaled drug product for the treatment of traumatic brain injury...
Drug Research
UNC researchers develop potential universal coronavirus vaccine
Scientists at the University of North Carolina Gillings School of Global Public Health have developed a universal vaccine that protected mice not just against COVID-19 but also other coronaviruses and triggered the immune system to fight off a dangerous...
News
Etihad Cargo and EFL Global successfully deliver vital antiretroviral drugs to Brazil
Etihad Cargo, the cargo and logistics arm of Abu Dhabi’s Etihad Aviation Group, and global supply chain company EFL Global, have successfully carried a vital consignment of antiretroviral drugs from India to Brazil.
The shipment, which weighed more than 55,000kg,...
News
Schreiner MediPharm and Plas-Tech Engineering Collaborate to Offer Full Service First-opening Indication for Prefilled Syringes
Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, and Plas-Tech Engineering, an expert in prefillable polymer syringes, have entered into a collaborative partnership for Cap-Lock – an innovative first-opening indication for prefilled...
News
Novo Nordisk Partners With Seattle Biopharm to Research, Develop Obesity Therapies
Seattle-based clinical-stage biopharmaceutical company Lumen Bioscience is teaming up with Novo Nordisk to explore research and development opportunities within obesity, among other metabolic disorders.
The collaboration will harness Lumen's drug development and manufacturing platform alongside Novo Nordisk's experience in R&D...
News
SGD Pharma speeds up time to market with industry first Ready-to-Use SG EZ-fill Nest & Tub packaging solution for molded glass vials for parenteral...
SGD Pharma announces that its 20ml EasyLyo molded glass Type I vials are now available Ready-to-Use (RTU) in SG EZ-fill® Nest & Tub – an industry- recognized state-of-the-art secondary packaging format.
Increased demand for parenteral drugs generated by the Covid-19...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















